Published in MAbs on December 29, 2015
Fcgamma receptors as regulators of immune responses. Nat Rev Immunol (2008) 11.34
Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med (2004) 10.91
Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A (1991) 5.94
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife (2012) 5.18
Potent antibody therapeutics by design. Nat Rev Immunol (2006) 4.87
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A (2008) 4.67
Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A (2002) 4.52
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology (2004) 4.12
Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov (2006) 3.08
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology (2013) 2.72
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
Passive antibody therapy for infectious diseases. Nat Rev Microbiol (2004) 2.64
Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis (2009) 2.62
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science (1985) 2.47
The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol (2007) 2.19
Clinical significance of hepatitis B virus genotypes. Hepatology (2002) 1.82
Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology (1996) 1.80
Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol (2007) 1.80
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology (2007) 1.71
Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol (2003) 1.65
Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine (1989) 1.61
Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol (2008) 1.49
Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol (1994) 1.43
Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PLoS One (2009) 1.33
Therapeutic antibodies: current state and future trends--is a paradigm change coming soon? Methods Mol Biol (2009) 1.32
Optimization of Fc-mediated effector functions of monoclonal antibodies. Curr Opin Biotechnol (2009) 1.30
A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology (2013) 1.11
Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology (2000) 1.02
In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen. J Med Virol (1997) 1.00
Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol (2014) 0.98
Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol (1996) 0.98
Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods (2001) 0.95
Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1993) 0.91
Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity. Front Immunol (2015) 0.89
Gene expression profile of transgenic mouse kidney reveals pathogenesis of hepatitis B virus associated nephropathy. J Med Virol (2006) 0.84
In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee. J Gen Virol (1999) 0.82
Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A. J Med Virol (2007) 0.81